Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Ultra-low frequency labeling of single cell lineages in Drosophila.

Snee M, Lee WC, Beehler-Evans R, Micchelli CA.

Dev Biol. 2020 Jan 1;457(1):9-12. doi: 10.1016/j.ydbio.2019.09.008. Epub 2019 Sep 21.

PMID:
31550481
2.

Structure and Properties of a Natural Competence-Associated Pilin Suggest a Unique Pilus Tip-Associated DNA Receptor.

Salleh MZ, Karuppiah V, Snee M, Thistlethwaite A, Levy CW, Knight D, Derrick JP.

mBio. 2019 Jun 11;10(3). pii: e00614-19. doi: 10.1128/mBio.00614-19.

3.

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial.

Manoharan P, Salem A, Mistry H, Gornall M, Harden S, Julyan P, Locke I, McAleese J, McMenemin R, Mohammed N, Snee M, Woods S, Westwood T, Faivre-Finn C.

J Thorac Oncol. 2019 Jul;14(7):1296-1305. doi: 10.1016/j.jtho.2019.03.023. Epub 2019 Apr 16.

4.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, Edwards JG, Ezhil V, Gilligan D, Hatton M, Jegannathen A, Mansy T, Peake MD, Pemberton L, Rintoul RC, Snee M, Ryder WD, Taylor P, Faivre-Finn C.

J Clin Oncol. 2019 May 10;37(14):1200-1208. doi: 10.1200/JCO.18.01678. Epub 2019 Mar 28.

5.

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.

Spencer KL, Kennedy MPT, Lummis KL, Ellames DAB, Snee M, Brunelli A, Franks K, Callister MEJ.

Eur Respir J. 2019 Jun 20;53(6). pii: 1801568. doi: 10.1183/13993003.01568-2018. Print 2019 Jun.

6.

Quality of life comparing carboplatin with cisplatin in the treatment of non-small cell lung cancer.

Snee M.

Eur J Cancer. 2018 Mar;91:167. doi: 10.1016/j.ejca.2017.11.019. Epub 2018 Jan 2. No abstract available.

PMID:
29301719
7.

Multiple cis-acting signals, some weak by necessity, collectively direct robust transport of oskar mRNA to the oocyte.

Ryu YH, Kenny A, Gim Y, Snee M, Macdonald PM.

J Cell Sci. 2017 Sep 15;130(18):3060-3071. doi: 10.1242/jcs.202069. Epub 2017 Jul 31.

8.

The extracellular metalloprotease AdamTS-A anchors neural lineages in place within and preserves the architecture of the central nervous system.

Skeath JB, Wilson BA, Romero SE, Snee MJ, Zhu Y, Lacin H.

Development. 2017 Sep 1;144(17):3102-3113. doi: 10.1242/dev.145854. Epub 2017 Jul 31.

9.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team.

Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.

11.
12.

Longstanding Challenges in Lung Cancer: Are We Meeting Them?

Snee M, Hatton MQ.

Clin Oncol (R Coll Radiol). 2016 Nov;28(11):669-671. doi: 10.1016/j.clon.2016.08.003. Epub 2016 Aug 21. No abstract available.

PMID:
27555083
13.

Collaborative Control of Cell Cycle Progression by the RNA Exonuclease Dis3 and Ras Is Conserved Across Species.

Snee MJ, Wilson WC, Zhu Y, Chen SY, Wilson BA, Kseib C, O'Neal J, Mahajan N, Tomasson MH, Arur S, Skeath JB.

Genetics. 2016 Jun;203(2):749-62. doi: 10.1534/genetics.116.187930. Epub 2016 Mar 30.

14.

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.

Bayman N, Ardron D, Ashcroft L, Baldwin DR, Booton R, Darlison L, Edwards JG, Lang-Lazdunski L, Lester JF, Peake M, Rintoul RC, Snee M, Taylor P, Lunt C, Faivre-Finn C.

BMJ Open. 2016 Jan 27;6(1):e010589. doi: 10.1136/bmjopen-2015-010589.

15.
16.

Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.

Murray L, Karakaya E, Hinsley S, Naisbitt M, Lilley J, Snee M, Clarke K, Musunuru HB, Ramasamy S, Turner R, Franks K.

Br J Radiol. 2016;89(1058):20150628. doi: 10.1259/bjr.20150628.

17.

Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.

Soodgupta D, Zhou H, Beaino W, Lu L, Rettig M, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M.

J Nucl Med. 2016 Apr;57(4):640-5. doi: 10.2967/jnumed.115.164624. Epub 2016 Jan 7.

18.

Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.

Murray L, Ramasamy S, Lilley J, Snee M, Clarke K, Musunuru HB, Needham A, Turner R, Sangha V, Flatley M, Franks K.

Clin Oncol (R Coll Radiol). 2016 Jan;28(1):4-12. doi: 10.1016/j.clon.2015.09.007. Epub 2015 Oct 21.

PMID:
26474546
19.

Stereotactic ablative body radiotherapy for lung cancer.

Franks KN, Jain P, Snee MP.

Clin Oncol (R Coll Radiol). 2015 May;27(5):280-9. doi: 10.1016/j.clon.2015.01.006. Epub 2015 Mar 4.

PMID:
25746732
20.

Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned.

Faivre-Finn C, Snee M.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):487-9. doi: 10.1016/j.ijrobp.2014.05.044. Epub 2014 Sep 26. No abstract available.

PMID:
25304944
21.

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status.

Maguire J, Khan I, McMenemin R, O'Rourke N, McNee S, Kelly V, Peedell C, Snee M.

Eur J Cancer. 2014 Nov;50(17):2939-49. doi: 10.1016/j.ejca.2014.07.009. Epub 2014 Oct 7.

PMID:
25304298
22.

Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.

Robson JM, Vaidyanathan S, Cheyne L, Snee M, Franks K, Callister ME.

Clin Lung Cancer. 2014 Nov;15(6):466-9. doi: 10.1016/j.cllc.2014.07.006. Epub 2014 Aug 15.

PMID:
25220208
23.

Bevacizumab in non-small cell lung cancer: an overview of practice in the era of molecular testing.

Snee M.

Clin Oncol (R Coll Radiol). 2014 Aug;26(8):468-72. doi: 10.1016/j.clon.2014.05.004. Epub 2014 Jun 6. Review.

PMID:
24909702
24.

Heparin prophylaxis has no benefit in medical patients.

Snee M.

BMJ. 2012 Jul 31;345:e4940. doi: 10.1136/bmj.e4940. No abstract available.

PMID:
22851581
25.

Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.

Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, Snee M, Skailes G, Hatton M, Erridge S, Mohammed N.

Lung Cancer. 2012 Sep;77(3):532-6. doi: 10.1016/j.lungcan.2012.05.089. Epub 2012 Jun 4.

PMID:
22672970
26.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, Snee M, O'Brien M, Thomas G, Senan S, O'Byrne K, Kilburn LS, Spicer J, Landau D, Edwards J, Coombes G, Darlison L, Peto J; MARS trialists.

Lancet Oncol. 2011 Aug;12(8):763-72. doi: 10.1016/S1470-2045(11)70149-8. Epub 2011 Jun 30.

27.

Guidelines on the radical management of patients with lung cancer.

Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, Kerr K, Macfie A, McGuigan J, Padley S, Popat S, Screaton N, Snee M, Waller D, Warburton C, Win T; British Thoracic Society; Society for Cardiothoracic Surgery in Great Britain and Ireland.

Thorax. 2010 Oct;65 Suppl 3:iii1-27. doi: 10.1136/thx.2010.145938.

PMID:
20940263
28.

Improving survival with thoracic radiotherapy in patients with small cell lung cancer. The CONVERT and the REST Trials.

Faivre-Finn C, Blackhall F, Snee M, Harden S, Hulse P, Lorigan P.

Clin Oncol (R Coll Radiol). 2010 Sep;22(7):547-9. doi: 10.1016/j.clon.2010.05.008. Epub 2010 Jun 23. No abstract available.

PMID:
20576408
29.

BREs mediate both repression and activation of oskar mRNA translation and act in trans.

Reveal B, Yan N, Snee MJ, Pai CI, Gim Y, Macdonald PM.

Dev Cell. 2010 Mar 16;18(3):496-502. doi: 10.1016/j.devcel.2009.12.021.

30.

The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study.

Treasure T, Waller D, Tan C, Entwisle J, O'Brien M, O'Byrne K, Thomas G, Snee M, Spicer J, Landau D, Lang-Lazdunski L, Bliss J, Peckitt C, Rogers S, Marriage Née Denholm E, Coombes G, Webster-Smith M, Peto J.

J Thorac Oncol. 2009 Oct;4(10):1254-8. doi: 10.1097/JTO.0b013e3181ae26ae.

31.

Dynamic organization and plasticity of sponge bodies.

Snee MJ, Macdonald PM.

Dev Dyn. 2009 Apr;238(4):918-30. doi: 10.1002/dvdy.21914.

32.

miRNA-dependent translational repression in the Drosophila ovary.

Reich J, Snee MJ, Macdonald PM.

PLoS One. 2009;4(3):e4669. doi: 10.1371/journal.pone.0004669. Epub 2009 Mar 2.

33.

Bicaudal C and trailer hitch have similar roles in gurken mRNA localization and cytoskeletal organization.

Snee MJ, Macdonald PM.

Dev Biol. 2009 Apr 15;328(2):434-44. doi: 10.1016/j.ydbio.2009.02.003. Epub 2009 Feb 13.

34.

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.

Slotman BJ, Mauer ME, Bottomley A, Faivre-Finn C, Kramer GW, Rankin EM, Snee M, Hatton M, Postmus PE, Collette L, Senan S.

J Clin Oncol. 2009 Jan 1;27(1):78-84. doi: 10.1200/JCO.2008.17.0746. Epub 2008 Dec 1. Erratum in: J Clin Oncol. 2009 Feb 20;27(6):1002.

35.

[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival].

Slotman BJ, Faivre-Finn C, Kramer GW, Rankin E, Snee M, Hatton M, Postmus PE, Collette L, Musat E, Senan S.

Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):1000-4. Dutch.

PMID:
18549175
36.

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.

Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, Nicholson AG, O'Brien M, Peake M, Rudd R, Snee M, Steele J, Girling DJ, Nankivell M, Pugh C, Parmar MK; MS01 Trial Management Group.

Lancet. 2008 May 17;371(9625):1685-94. doi: 10.1016/S0140-6736(08)60727-8.

37.

Two distinct domains of Bruno bind specifically to the oskar mRNA.

Snee M, Benz D, Jen J, Macdonald PM.

RNA Biol. 2008 Jan-Mar;5(1):1-9.

PMID:
18388491
38.

Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer.

Lee SM, James L, Buchler T, Snee M, Ellis P, Hackshaw A.

Lung Cancer. 2008 Mar;59(3):364-8. Epub 2007 Oct 24.

PMID:
17920723
39.

Prophylactic cranial irradiation in extensive small-cell lung cancer.

Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S; EORTC Radiation Oncology Group and Lung Cancer Group.

N Engl J Med. 2007 Aug 16;357(7):664-72.

40.
41.

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK; London Lung Cancer Group.

J Clin Oncol. 2006 Aug 20;24(24):3823-30.

PMID:
16921033
42.

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).

Booton R, Lorigan P, Anderson H, Baka S, Ashcroft L, Nicolson M, O'Brien M, Dunlop D, O'Byrne K, Laurence V, Snee M, Dark G, Thatcher N.

Ann Oncol. 2006 Jul;17(7):1111-9. Epub 2006 Apr 7.

43.

Low-dose prophylactic cranial irradiation in patients with poor prognosis small-cell lung cancer.

Henry AM, Snee MP.

Clin Oncol (R Coll Radiol). 2006 Mar;18(2):129-32.

PMID:
16523813
44.

Recognition of the bcd mRNA localization signal in Drosophila embryos and ovaries.

Snee MJ, Arn EA, Bullock SL, Macdonald PM.

Mol Cell Biol. 2005 Feb;25(4):1501-10.

45.

hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere.

Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, Snee MJ, Smith R.

Nucleic Acids Res. 2005 Jan 19;33(2):486-96. Print 2005.

47.

Aggressive management of non-small cell lung cancer with synchronous solitary brain metastasis.

Vasudev NS, Crosse BA, Snee M, Joffe JK.

Clin Oncol (R Coll Radiol). 2004 Apr;16(2):158-9. No abstract available.

PMID:
15074744
48.

Technique of radical postoperative radiotherapy after pneumonectomy for mesothelioma.

Snee MP, Lilley J.

Clin Oncol (R Coll Radiol). 2003 Jun;15(4):189-92. No abstract available.

PMID:
12846497
49.

Modified Ifosphamide/CarboPlatin/Etoposide.

Snee MP.

Clin Oncol (R Coll Radiol). 2003 May;15(3):165; author reply 165. No abstract available.

PMID:
12801057
50.

RNA trafficking and stabilization elements associate with multiple brain proteins.

Snee M, Kidd GJ, Munro TP, Smith R.

J Cell Sci. 2002 Dec 1;115(Pt 23):4661-9.

Supplemental Content

Support Center